{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:32:14Z","timestamp":1793388734079,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jfma.2022.05.010","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T09:07:42Z","timestamp":1655197662000},"page":"2393-2407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["2022 Taiwan lipid guidelines for primary prevention"],"prefix":"10.1016","volume":"121","author":[{"given":"Po-Hsun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-1166","authenticated-orcid":false,"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9644-2855","authenticated-orcid":false,"given":"Hung-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1928-5339","authenticated-orcid":false,"given":"Hsin-Yun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-3159","authenticated-orcid":false,"given":"Chih-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-2081","authenticated-orcid":false,"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chieh","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-9234","authenticated-orcid":false,"given":"Yih-Jer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3206-0908","authenticated-orcid":false,"given":"Hung-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Harn","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2022.05.010_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jfma.2022.05.010_bib3","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jfma.2022.05.010_bib5","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2022.05.010_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/eurheartj\/ehr035","article-title":"Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of > 40000 patients","volume":"32","author":"Mills","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrcardio.2013.80","article-title":"Statins in the primary prevention of cardiovascular disease","volume":"10","author":"Reiner","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019695","article-title":"Does lowering low-density lipoprotein cholesterol with statin restore low risk in middle-aged adults? Analysis of the observational MESA Study","volume":"10","author":"Liu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2022.05.010_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116513","article-title":"Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan","volume":"10","author":"Ho","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2022.05.010_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jfma.2016.11.013","article-title":"2017 Taiwan lipid guidelines for high risk patients","volume":"116","author":"Li","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2022.05.010_bib11","first-page":"238","article-title":"Diet and health trends in Taiwan: comparison of two nutrition and health surveys from 1993\u20131996 and 2005\u20132008","volume":"20","author":"Pan","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.jfma.2022.05.010_bib12","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1001\/jama.1990.03450230054029","article-title":"Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2022.05.010_bib13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/hrt.2005.081760","article-title":"Childhood risk factors for adult cardiovascular disease and primary prevention in childhood","volume":"92","author":"Celermajer","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jfma.2022.05.010_bib15","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib16","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PVNA guidelines on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guideline","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4181","article-title":"Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2","volume":"344","author":"Collins","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2022.05.010_bib20","first-page":"598","volume":"38","author":"DeFilippis","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib21","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2022.05.010_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2012.03.017","article-title":"Constructing a point-based prediction model for the risk of coronary artery disease in a Chinese community: a report from a cohort study in Taiwan","volume":"157","author":"Chien","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib23","article-title":"Diagnostic accuracy of urine protein\/creatinine ratio is influenced by urine concentration","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2022.05.010_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2337\/diacare.10.4.414","article-title":"Single-void urine samples can be used to estimate quantitative microalbuminuria","volume":"10","author":"Nathan","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2022.05.010_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM198312223092503","article-title":"Use of single voided urine samples to estimate quantitative proteinuria","volume":"309","author":"Ginsberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archinte.1987.00370050135022","article-title":"Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples","volume":"147","author":"Schwab","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib28","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jfma.2022.05.010_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib32","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1161\/CIRCULATIONAHA.117.027966","volume":"136","author":"Vallejo-Vaz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib33","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.117.032321","article-title":"Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999\u20132014)","volume":"137","author":"Bucholz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib34","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib35","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2005.07.020","article-title":"Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease","volume":"186","author":"Heng","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jfma.2022.05.010_bib37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","article-title":"Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?","volume":"27","author":"Tan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2022.05.010_bib38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5551\/jat.GL2017","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017","volume":"25","author":"Kinoshita","year":"2018","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.jfma.2022.05.010_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3904\/kjim.2019.188","article-title":"2018 Guidelines for the management of dyslipidemia","volume":"34","author":"Rhee","year":"2019","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-020-01792-7","article-title":"LDL-C: lower is better for longer \u2013 even at low risk","volume":"18","author":"Penson","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib42","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIRCULATIONAHA.119.043406","article-title":"Low density lipoprotein cholesterol \u2013 lowering strategies and population health time to move to a cumulative exposure model","volume":"141","author":"Brandts","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib44","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.115.018383","article-title":"Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease","volume":"133","author":"Thanassoulis","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCRESAHA.118.313348","article-title":"The Mediterranean diet and cardiovascular health","volume":"124","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jfma.2022.05.010_bib46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archinte.168.7.713","article-title":"Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women","volume":"168","author":"Fung","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251189","article-title":"The Healthy Taiwanese Eating Approach is inversely associated with all-cause and cause-specific mortality: a prospective study on the Nutrition and Health Survey in Taiwan, 1993\u20131996","volume":"16","author":"Chuang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2022.05.010_bib48","doi-asserted-by":"crossref","first-page":"e1112","DOI":"10.1212\/WNL.0000000000009093","article-title":"Vegetarian diet and incidence of total, ischemic, and hemorrhagic stroke in 2 cohorts in Taiwan","volume":"94","author":"Chiu","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2022.05.010_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/nu10020143","article-title":"Association of dietary patterns with components of metabolic syndrome and inflammation among middle-aged and older adults with metabolic syndrome in Taiwan","volume":"10","author":"Syauqy","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2022.05.010_bib50","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib51","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamainternmed.2016.4182","article-title":"Association of animal and plant protein intake with all-cause and cause-specific mortality","volume":"176","author":"Song","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/nu12020334","article-title":"Defining a healthy diet: evidence for the role of contemporary dietary patterns in health and disease","volume":"12","author":"Cena","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2022.05.010_bib53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jama.2017.0947","article-title":"Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States","volume":"317","author":"Micha","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2022.05.010_bib54","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib55","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.3390\/nu12123774","article-title":"The effect of low-fat and low-carbohydrate diets on weight loss and lipid levels: a systematic review and meta-analysis","volume":"12","author":"Chawla","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2022.05.010_bib56","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/nu10060780","article-title":"Dietary cholesterol and the lack of evidence in cardiovascular disease","volume":"10","author":"Soliman","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2022.05.010_bib57","first-page":"8","article-title":"Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations","volume":"9","author":"Fernandez","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jfma.2022.05.010_bib58","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1161\/01.CIR.88.6.2771","article-title":"Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox","volume":"88","author":"Artaud-Wild","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/foods7030029","article-title":"Dairy fats and cardiovascular disease: do we really need to be concerned?","volume":"7","author":"Lordan","year":"2018","journal-title":"Foods"},{"key":"10.1016\/j.jfma.2022.05.010_bib60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2008.03.092","article-title":"Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis","volume":"136","author":"Eslick","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib61","first-page":"CD003177","article-title":"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease","volume":"11","author":"Abdelhamid","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2022.05.010_bib62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain \u2013 a systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jfma.2022.05.010_bib63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ejcn.2011.64","article-title":"Effects of cocoa products\/dark chocolate on serum lipids: a meta-analysis","volume":"65","author":"Tokede","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jfma.2022.05.010_bib64","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/nutrit\/nuz037","article-title":"Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis","volume":"77","author":"Dibaba","year":"2019","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jfma.2022.05.010_bib65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/mnfr.201500425","article-title":"Increase of circulating cholesterol in vitamin D deficiency is linked to reduced vitamin D receptor activity via the Insig-2\/SREBP-2 pathway","volume":"60","author":"Li","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jfma.2022.05.010_bib66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3945\/ajcn.110.010926","article-title":"Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials","volume":"94","author":"Zheng","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jfma.2022.05.010_bib67","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008814","article-title":"Tea consumption and longitudinal change in high-density lipoprotein cholesterol concentration in Chinese adults","volume":"7","author":"Huang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2022.05.010_bib68","first-page":"CD009387","article-title":"Exercise for people with high cardiovascular risk","author":"Seron","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2022.05.010_bib69","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa020194","article-title":"Effects of the amount and intensity of exercise on plasma lipoproteins","volume":"347","author":"Kraus","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib70","first-page":"CD003817","article-title":"Exercise for overweight or obesity","author":"Shaw","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2022.05.010_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12970-021-00436-2","article-title":"A large-scale observational study linking various kinds of physical exercise to lipoprotein-lipid profile","volume":"18","author":"Lin","year":"2021","journal-title":"J Int Soc Sports Nutr"},{"key":"10.1016\/j.jfma.2022.05.010_bib72","article-title":"Moderate-to-vigorous physical activity and all-cause mortality: do bouts matter?","volume":"7","author":"Saint-Maurice","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2022.05.010_bib73","doi-asserted-by":"crossref","first-page":"d636","DOI":"10.1136\/bmj.d636","article-title":"Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies","volume":"342","author":"Brien","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2022.05.010_bib74","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/nu12040912","article-title":"The effect of alcohol on cardiovascular risk factors: is there new information?","volume":"12","author":"Minzer","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jfma.2022.05.010_bib75","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.1136\/bmj.d671","article-title":"Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis","volume":"342","author":"Ronksley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2022.05.010_bib76","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/archinte.166.22.2437","article-title":"Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies","volume":"166","author":"De Castelnuovo","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-140-6-200403160-00011","article-title":"Effect of alcohol consumption on diabetes mellitus: a systematic review","volume":"140","author":"Howard","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib78","doi-asserted-by":"crossref","first-page":"g4164","DOI":"10.1136\/bmj.g4164","article-title":"Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data","volume":"349","author":"Holmes","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2022.05.010_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/16066350500497983","article-title":"Moderate alcohol use and reduced mortality risk: systematic error in prospective studies","volume":"14","author":"Fillmore","year":"2006","journal-title":"Addiction Res Theor"},{"key":"10.1016\/j.jfma.2022.05.010_bib80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amepre.2005.01.011","article-title":"Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults","volume":"28","author":"Naimi","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/add.12828","article-title":"Has the leaning tower of presumed health benefits from \u2018moderate\u2019 alcohol use finally collapsed?","volume":"110","author":"Chikritzhs","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jfma.2022.05.010_bib82","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599912 current drinkers in 83 prospective studies","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.05.010_bib83","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(18)31772-0","article-title":"Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China","volume":"393","author":"Millwood","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.05.010_bib84","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1469-1809.2009.00517.x","article-title":"Refined geographic distribution of the oriental ALDH2\u2217504Lys (nee 487Lys) variant","volume":"73","author":"Li","year":"2009","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.jfma.2022.05.010_bib86","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1360-0443.2003.00467.x","article-title":"The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview","volume":"98","author":"Rehm","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jfma.2022.05.010_bib87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000072222","article-title":"Alcohol as a risk factor for global burden of disease","volume":"9","author":"Rehm","year":"2003","journal-title":"Eur Addiction Res"},{"key":"10.1016\/j.jfma.2022.05.010_bib88","series-title":"Dietary guideline for Americans, 2020\u20132025","first-page":"49","article-title":"Nutrition and health across the lifespan: the guidelines and key recommendations","year":"2020"},{"key":"10.1016\/j.jfma.2022.05.010_bib89","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jech.54.5.328","article-title":"The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox","volume":"54","author":"Britton","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jfma.2022.05.010_bib90","author":"Tobacco\/World Health Organization"},{"key":"10.1016\/j.jfma.2022.05.010_bib91","author":"Health Promotion Administration, Ministry of Health and Welfare"},{"key":"10.1016\/j.jfma.2022.05.010_bib92","doi-asserted-by":"crossref","first-page":"h1551","DOI":"10.1136\/bmj.h1551","article-title":"Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium","volume":"350","author":"Mons","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2022.05.010_bib93","article-title":"An effective strategy to activate physicians to promote high cardiovascular risk patients to quit smoking","author":"Su","year":"2022","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jfma.2022.05.010_bib94","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-2600(15)00521-4","article-title":"E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis","volume":"4","author":"Kalkhoran","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib95","first-page":"CD010216","article-title":"Electronic cigarettes for smoking cessation","volume":"4","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2022.05.010_bib96","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1916433","article-title":"Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI","volume":"382","author":"Blount","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib97","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.jacc.2016.03.569","article-title":"Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers","volume":"67","author":"Vlachopoulos","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib98","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11906-020-01119-0","article-title":"Electronic cigarette use and blood pressure endpoints: a systematic review","volume":"23","author":"Martinez-Morata","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jfma.2022.05.010_bib99","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force","volume":"316","author":"Chou","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2022.05.010_bib100","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib101","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib102","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.05.010_bib103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2018.12.007","article-title":"Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: a systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants","volume":"210","author":"Yebyo","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib104","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ahj.2014.03.019","article-title":"A systematic review of statin-induced muscle problems in clinical trials","volume":"168","author":"Ganga","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jfma.2022.05.010_bib105","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jfma.2018.11.017","article-title":"2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance","volume":"118","author":"Chien","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2022.05.010_bib106","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Stott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.05.010_bib107","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.05.010_bib108","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib109","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.118.039415","article-title":"Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (EWTOPIA 75): a randomized, controlled trial","volume":"140","author":"Ouchi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd3879","article-title":"Cholesterol-lowering blockbuster candidates speed into Phase III trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jfma.2022.05.010_bib111","first-page":"CD011748","article-title":"PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease","volume":"10","author":"Schmidt","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2022.05.010_bib112","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib113","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.atherosclerosis.2012.08.039","article-title":"Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study","volume":"225","author":"Sniderman","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jfma.2022.05.010_bib114","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","article-title":"Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men","volume":"112","author":"Pischon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2022.05.010_bib115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib116","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-017-08741-0","article-title":"Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2022.05.010_bib117","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jfma.2018.05.020","article-title":"On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease \u2013 the multi-center T-SPARCLE registry study","volume":"117","author":"Ho","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2022.05.010_bib118","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2022.05.010_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2022.05.010_bib121","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2022.05.010_bib122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.05.010_bib123","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622002157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622002157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:48:04Z","timestamp":1760539684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664622002157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":121,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0929664622002157"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2022.05.010","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2022 Taiwan lipid guidelines for primary prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2022.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}